Researchers from Flinders University and University of South Australia have unveiled a promising new strategy that could be used to treat the most aggressive forms of prostate cancer. Their study, published in British Journal ...
Sep 2, 2024
0
28
Investigators have discovered that aberrant activation of a specific oncoprotein drives key tumor-promoting changes in the prostate tissue microenvironment during cancer progression, according to a Northwestern Medicine study ...
Aug 29, 2024
0
19
Researchers at the Medical College of Georgia at Augusta University are searching for a better way to understand why many men with prostate cancer end up with Alzheimer's disease, and whether it's the standard hormone therapy ...
Aug 29, 2024
0
29
In a recent comprehensive review published in Cyborg Bionic Systems, researchers detail significant advances in the identification and application of biomarkers for prostate cancer (PCa). This critical insight is pivotal ...
Aug 23, 2024
0
0
Prostate cancer is often treated by a robotic keyhole surgery called a robotic-assisted radical prostatectomy. Accompanying this surgery is an MRI scan that tells the surgeon where the cancer is within the prostate.
Aug 23, 2024
0
0
The anti-cancer drug olaparib may be effective in treating biochemically recurrent prostate cancer without accompanying hormone therapy for men who have mutations in genes such as BRCA2, according to results of a Phase II ...
Aug 22, 2024
0
0
Scientists at the Icahn School of Medicine at Mount Sinai have identified a new class of RNAs packed into tiny particles known as extracellular vesicles (EVs) that could revolutionize how cancer and other diseases are diagnosed. ...
Aug 17, 2024
0
66
For years, the treatment of early-stage prostate cancers that haven't spread beyond the organ has often included the removal of nearby lymph nodes in the pelvis. It's done as a precaution and as a means of "staging" the disease.
Aug 12, 2024
0
0
New Corewell Health research suggests an MRI scan can help predict whether patients with intermediate-risk prostate cancer (cancer confined to the entire prostate) may have more aggressive cancer in five years. Knowing this ...
Aug 7, 2024
0
0
A protein called Meteorin-like (METRNL) in the tumor microenvironment saps energy from T cells, thereby severely limiting their ability to fight cancer, according to new research directed by investigators at the Johns Hopkins ...
Aug 6, 2024
0
45
